New guidelines for the management of adult community-acquired pneumonia

Current Opinion in Infectious Diseases

Volumn 20, Issue 2, 2007, Pages 170-176

  Armitage, Kathryn ^a   Woodhead, Mark ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adherence; Antibiotics; Community acquired pneumonia; Guidelines

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MOXIFLOXACIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; UNINDEXED DRUG; UREIDOPENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; CLINICAL EXAMINATION; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; DRUG MEGADOSE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ORGANIZATION; HOSPITAL ADMISSION; HUMAN; INFLUENZA VIRUS A; INTENSIVE CARE UNIT; LEGIONELLA PNEUMOPHILA; MICROBIOLOGY; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; RISK ASSESSMENT; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY;

ADULT; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; PNEUMONIA, BACTERIAL; PRACTICE GUIDELINES; SEVERITY OF ILLNESS INDEX;

EID: 33847377086     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3280803d70     Document Type: Review

References (27)

1. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003; 37:1405-1433.
2. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005; 26:1138-1180. A comprehensive review of the management of adult respiratory tract infections including community-acquired pneumonia, exacerbations of chronic obstructive pulmonary disease and bronchiectasis.
3. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163:1730-1754.
4. Macfarlane JT, Boswell T, Douglas G, et al. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 2001; 56 (Suppl 4):IV1-IV64.
5. Macfarlane JT, Boldy D. 2004 update of BTS pneumonia guidelines: what's new? Thorax 2004; 59:364-366.
6. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148:1418-1426
7. Miyashita N, Matsushima T, Oka M. The JRS Guidelines for the Management of Community-acquired Pneumonia in Adults: an update and new recommendations. Intern Med 2006; 45:419-428.
8. Mandell LA, Marrie TJ, Grossman RF, et al. Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society. Can Respir J 2000; 7:371-382.
9. Hedlund J, Stralin K, Ortqvist A, Holmberg H. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scand J Infect Dis 2005; 37:791-805.
10. Fine MJ, Auble TE, Yearly DM, et al. A prediction rule to identify low risk patients with community-acquired pneumonia. N Engl J Med 1997; 336:243-250.
11. Neill AM, Martin IR, Weir R, et al. Community-acquired pneumonia aetiology and usefulness of severity criteria on admission. Thorax 1996; 51:1010-1016.
12. Marrie TJ, Lau CY, Wheeler SL, Wong CJ, et al. A contolled trial of a critical pathway for treatment of community-acquired pneumonia. JAMA 2000; 283:749-755.
13. Lim WS, Van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-382.
14. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA 1997; 278:2080-2084.
15. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalised with community-acquired pneumonia. Arch Intern Med 2004; 164:637-644.
16. Mandell LA. Update on community-acquired pneumonia. Postgrad Med 2005; 118:35.
17. Johnson DM, Stilwell MG, Fritsche TR, Jones RN. Emergence of multidrug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (1999-2003). Diagn Microbiol Infect Dis 2006; 56:69-74.
18. European Antimicrobial Resistance Surveillance System. European resistance rates [online]. Bilthoven: EARSS; 2006. http://www.rivm.nl/earss
19. Moran G. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate use of fluoroquinolones. J Emerg Med 2006; 30:377-387.
20. Pepin J, Saheb N, Coulombe M, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea. Clin Infect Dis 2005; 41:1254-1260.
21. American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator associated and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 17:388-416.
22. Menendez R, Ferrando D, Valles JM, Vallterra J. Influence of deviation from guidelines on the outcome of community-acquired pneumonia. Chest 2002; 122:612-617.
23. Yealy DM, Auble TE, Stone RA, Lave JR. Effects of increasing the intensity of implementing pneumonia guidelines. Ann Intern Med 2005; 143:881-894.
24. Menendez R, Torres A, Zalacain R, Aspa J. Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Med 2005; 172:757-762.
25. Ramirez JA, and Community-Acquired Pneumonia Organization Investigators. Worldwide perspective of the quality of care provided to hospitalized patients with community-acquired pneumonia: results from the CAPO International Cohort Study. Semin Respir Crit Care Med 2005; 26:543-552.
26. Maxwell DJ, McIntosh KA, Pulver LK, Easton KL. Empirical management of community acquired pneumonia in Australian emergency departments. Med J Aust 2005; 183:520-524.
27. Woodhead M. Community-acquired pneumonia guidelines: much guidance, but not much evidence. Eur Respir J 2002; 20:1-3.